The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

KU Hematology & Medical Oncology Review 2019
W

Anti-PD-1 Therapy and Dose Modification in Advanced Gastroesophageal Cancers: How Much Do We Know?

By KU Hematology & Medical Oncology Review 2019 FEATURING Weijing Sun
By KU Hematology & Medical Oncology Review 2019 FEATURING Weijing Sun
0 views
August 23, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Featured Video

08:18
Insights from 2023 ASH Annual Meeting

Treatment Strategies for Hematocrit Control in PV

Feat. A. Zhou
Gastrointestinal
14:39
KU Hematology & Medical Oncology Review 2019

KU ASCO 2019 Updates on Pancreatic Cancer: Maintenance Olaparib and …

Feat. R. Al-Rajabi
16:20
KU Hematology & Medical Oncology Review 2019

KU ASCO 2019 Updates on Hepatobiliary Cancer: Pembrolizumab vs. Best…

Feat. R. Al-Rajabi
19:12
KU Hematology & Medical Oncology Review 2019

Management of Toxicities in Neoadjuvant (Perioperative) Chemotherapy…

Feat. W. Sun
18:29
KU Hematology & Medical Oncology Review 2019

Anti-PD-1 Therapy and Dose Modification in Advanced Gastroesophageal…

Feat. W. Sun